UH Rainbow and Children’s Hospital is seeing double the number of children with RSV in their emergency department, compared with a month ago. And MetroHealth has seen a 500% increase in the past month.
CLEVELAND, Ohio — Respiratory syncytial virus, also called RSV, came roaring into Greater Cleveland at the end of September and has been steadily growing, now filling area hospitals with sick children.in their emergency department, compared with a month ago. And MetroHealth has seen a 500% increase in the last month.
The vaccine could be available next winter., after gaining regulatory approval. However, the vaccine’s trial data has not been published or peer reviewed yet, news reports said. Among children under 5 in the United States, RSV is responsible for up to 500 deaths and 58,000 hospitalizations annually, according to the U.S. Centers for Disease Control and Prevention. The virus causes 177,000 hospitalizations and 14,000 deaths annually among those 65 and older.
MetroHealth System is experiencing a surge of children with RSV in its emergency and pediatric floors, up about 500% from last month. In October, MetroHealth admitted 17 RSV patients to its intensive care and regular inpatient pediatric department, compared to four this time last year.of RSV at its Akron and Youngstown medical centers, saidchief academic officer.
In 2020, RSV rates were very low, Forbes said. In the summer of 2021, Akron Children’s saw an unseasonal spike of RSV that tapered off by November. RSV symptoms include a runny nose, cough and headache. The flu comes with high fevers, body aches, headaches, cough and a runny nose. COVID-19 symptoms include fever, sore throat, possibly the loss of taste and smell, cough and body aches.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to seek regulatory approval as strong RSV vaccine data lifts hopesThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
Pfizer RSV vaccine given to pregnant mothers is effective at protecting newborns, company's data showsPfizer said it will submit an application to the Food and Drug Administration for the RSV vaccine's approval by the end of 2022.
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
Pfizer says study shows vaccinating pregnant women protects newborns from RSVThe preliminary results buoy hope that after decades of failure and frustration, vaccines against RSV may finally be getting close.
Read more »
RSV Vaccine Given During Pregnancy Protects Newborns: PfizerNew trial data from drugmaker Pfizer shows promising effectiveness of a vaccine given to mothers during pregnancy that later protects infants in their first months from the most devastating effects of respiratory syncytial virus, or RSV.
Read more »
Pfizer Says It Will Seek FDA Approval For A Maternal RSV Vaccine This YearInitial trail results of the maternal vaccine showed promising results for Pfizer. The pharmaceutical company will seek FDA approval this week.
Read more »